Loading...
Wir würden uns freuen, wenn du Teil unserer Community wirst. Tritt unserem Discord bei um dich mit uns und anderen Mitgliedern zu vernetzen!
- Ticker
- OBCK.F
- Price
- 69.70
- Stock movement up
- +- (0.00%)
- Company name
- Ottobock SE & Co. KGaA
- Exchange
- (F ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Instruments & Supplies
- Marktkapitalisierung
- -
- Ent-Wert
- -
- Preis/Umsatz
- -
- Preis/Buch
- -
- Div-Ertrag
- -
- Div Wachstum
- -
- Wachstumsjahre
- -
- FCF-Ausschüttung
- -
- Nachlaufendes KGV
- -
- Forward P/E
- -
- PEG
- -
- EPS-Wachstum
- -
- 1 Jahr Rückkehr
- -
- 3-Jahres-Rendite
- -
- 5-Jahres-Rendite
- -
- 10-Jahres-Rendite
- -
Zuletzt aktualisiert: 2025-12-17
DIVIDENDS
OBCK.F keine Dividenden ausschüttet
BEWERTUNG
Bewertungskennzahlen
Loading...
Daten zu den Bewertungsverhältnissen
| Nachlaufendes KGV | - |
| Preis zu OCF | - |
| Preis zu FCF | - |
| Preis zu EBITDA | - |
| EV zu EBITDA | - |
Bewertung (Umsatz/Buchwert)
Loading...
Bewertungsdaten (Umsatz/Buchwert)
| Preis zu Umsatz | - |
| Preis zum Buchen | - |
| EV zu Verkäufen | - |
FINANZEN
BESTANDSINFORMATIONEN
Aktienchart
Loading...
Daten zum Aktienkurs
| Öffnen Sie | 69.60 |
| Tageshöchststand | 70.35 |
| Tägliches Tief | 69.60 |
| Tägliches Volumen | 0K |
| Allzeithoch | 74.65 |
| 1-Jahres-Analystenschätzung | - |
| Beta | - |
| EPS (TTM) | - |
| Dividende je Aktie | 0.00 |
| Ex-Div-Datum | - |
| Nächstes Ergebnisdatum | - |
Nachteiliges Potenzial
Loading...
Nachteilige potenzielle Daten
| OBCK.F | S&P500 | |
| Aktueller Preisrückgang vom Allzeithoch | -6.63% | -1.49% |
| Höchster Preisrückgang | -9.24% | -19.00% |
| Datum des höchsten Rückgangs | 10 Dec 2025 | 8 Apr 2025 |
| Durchschnittlicher Rückgang vom Höchststand | -3.39% | -2.63% |
| Durchschnittliche Zeit bis zum neuen Höchststand | 7 days | 6 days |
| Maximale Zeit bis zum neuen Höchststand | 20 days | 89 days |
UNTERNEHMENSDATEN
Marketcap
-
Kategorie Marktkapitalisierung
Small-cap
Beschreibung
Ottobock SE & Co. KGaA designs and develops medical technology products and solutions for the people with limited mobility in the fields of prosthetics, orthotics, human mobility, and medical care worldwide. The company develops exo-prosthetics products, including microprocessor-controlled lower limb prosthesis systems, bionic prosthetic systems, michelangelo prosthetic hands, and liner and closure systems; temporary fittings for after accidents and injuries; ankle sprains products; fittings for partial paralysis of legs; and mechatronic orthosis systems. It also offers mobility solutions, such as manual and power wheelchairs and rehabilitation products that includes standing supports, seating systems, and seat cushions for active and athletic users. In addition, the company provides patient care and professional workshop management services and professional support services for spatial concepts and area utilization. Ottobock SE & Co. was formerly known as Otto Bock HealthCare GmbH and changed its name to Ottobock SE & Co. KGaA in April 2018. The company was founded in 1919 and is based in Duderstadt, Germany. Ottobock SE & Co. KGaA operates as a subsidiary of Näder Upside 2 Vermögensverwaltungs GmbH.
Mitarbeiter
9256
Investor Relations
-
SEC-Anmeldungen
CEO
Land
Germany
Stadt
Art des Bestands
-
CCC-Status
-
Häufigkeit der Ausschüttung
-
VERANSTALTUNGEN UND PRÄSENTATIONEN
VeranstaltungenPräsentationen
Loading...
DAS GESCHÄFT VERSTEHEN
Loading...
UNTERNEHMENSNACHRICHTEN
Alle NachrichtenPresseveröffentlichungen
Amid a mixed performance in European markets, with the pan-European STOXX Europe 600 Index slightly down and varied results across major indices like Germany's DAX and France's CAC 40, investors are c...
17. Dezember 2025
As global markets navigate the complexities of fluctuating interest rates and economic uncertainties, investors are keenly observing how these factors impact stock valuations. With major indices exper...
17. Dezember 2025
As the European market navigates mixed signals with indices like Germany's DAX seeing gains while others such as France's CAC 40 experience declines, investors are closely watching central bank polici...
17. Dezember 2025
As the European market navigates mixed performances, with Germany's DAX seeing gains while France's CAC 40 and the UK's FTSE 100 experienced declines, investors are keenly observing economic indicator...
16. Dezember 2025
As global markets navigate a period of mixed performance, with U.S. indices hitting all-time highs amid interest rate cuts and European markets showing varied results, investors are increasingly focus...
16. Dezember 2025
As European markets show mixed performance with the pan-European STOXX Europe 600 Index ending slightly lower, investors are closely watching the European Central Bank's potential policy moves amid ec...
16. Dezember 2025
As European markets navigate a mixed landscape, with the STOXX Europe 600 Index inching higher amid hopes for interest rate cuts in the U.S. and UK, investors are keenly observing opportunities that m...
12. Dezember 2025
As the European markets navigate a landscape marked by hopes of interest rate cuts and mixed economic signals, investors are closely watching for opportunities amid fluctuating indices. With the STOXX...
12. Dezember 2025
As the European market navigates mixed returns with hopes of interest rate cuts from major economies, investors are keenly observing opportunities that may arise from undervalued stocks. In this conte...
9. Dezember 2025
As global markets navigate the anticipation of interest rate cuts and mixed economic signals, investors are keenly observing how these developments influence stock valuations. Amidst this fluctuating ...
9. Dezember 2025
Nächste Seite